2.5 mg retatrutide results 12 Weeks on | What Now? Retatrutide just delivered one of

Semaglutide also improves sleep apnea markers, though with somewhat less dramatic reductions in AHI compared to tirzepatide

doi: 10.1056/NEJMoa1612917 16 GreenJBHernandezAFDAgostinoRBGrangerCBJanmohamedSJonesNPet al

These early findings have set new benchmarks for what pharmaceutical weight loss interventions might achieve, though it remains important to understand that larger Phase 3 trials are still ongoing to confirm these results in broader populations

If you have specific health conditions that make maintaining a healthy weight more difficult, we recommend working with your healthcare provider to answer any medical questions

Ongoing safety studies are planned to further evaluate and confirm the long-term safety of Amycretin

One strategy involves extending the initial 1mg phase to six or eight weeks instead of four